CANCER stem cells, which fuel the growth of fatal tumours, can be knocked out by a one-two combination of antibiotics and Vitamin C in a new experimental strategy, published by researchers at the University of Salford, UK.
The antibiotic, Doxycycline, followed by doses of ascorbic acid (Vitamin C), were surprisingly effective in killing the cancer stem cells under laboratory conditions, according to the research published in the journal Oncotarget.
In boxing terms, this would be the equivalent of two blows delivered in rapid succession; a left-hand jab, followed by a right cross.
The researchers say their method offers a new explanation for how to prevent cancer cells from becoming treatment-resistant and how combinations therapies can be developed to overcome drug resistance.
Starve cancer cells
Professor Michael Lisanti, who designed the study, explained: “We now know that a proportion of cancer cells escape chemotherapy and develop drug resistance; we established this new strategy to find out how they do it.
“We suspected the answer lay in the fact that certain cancer cells – which we call metabolically flexible – are able to switch their fuel source. Thus, when the drug treatment reduces the availability of a particular nutrient, the flexible cancer cells can feed themselves with an alternative energy source.”
This new combination approach prevents cancer cells from changing their diet (metabolically inflexible), and effectively starves them, by preventing them from using any other available types of bio-fuels.
The team at the University of Salford’s Biomedical Research Centre, added Doxycycline in ever increasing doses over a three-month period, to induce metabolic inflexibility. The result was to leave the cancer cells alive, but severely attenuated and depleted, so that they would be much more susceptible to starvation, by a second metabolic “punch”.
First, the researchers inhibited the tumour cell mitochondria, by restricting the cancer cells only to glucose as a fuel source; then, they took away their glucose, effectively starving the cancer cells to death.
“In this scenario, Vitamin C behaves as an inhibitor of glycolysis, which fuels energy production in mitochondria, the “powerhouse” of the cell, explained co-author Dr Federica Sotgia.
The Salford team recently showed Vitamin C to be up to ten times more effective at stopping cancer cell growth than pharmaceuticals such as 2-DG, but they say that when Vitamin C is combined with an antibiotic, it is up to ten times more effective, making it nearly 100 times more effective than 2-DG.
As Doxycycline and Vitamin C are both relatively non-toxic, this could dramatically reduce the possible side-effects of anti-cancer therapy.
The Salford team also identified eight other drugs that could be used as a “second-punch” after the antibiotic regime, including berberine (a natural product) – and a number of cheap non-toxic FDA approved drugs.
Professor Lisanti added: “This is further evidence that Vitamin C and other non-toxic compounds may have a role to play in the fight against cancer.
“Our results indicate it is a promising agent for clinical trials, and a as an add-on to more conventional therapies, to prevent tumour recurrence, further disease progression and metastasis.”
The Latest on: Cancer stem cells
- Cell Culture Market Is Projected To Grow At A CAGR Of 10.43% During The Period 2017-2025on November 19, 2019 at 9:39 pm
Market Restraints 2.1 High Cost of Cell Biology Research 2.2 Lack of Infrastructure for Cell-Based Research in Emerging Economies Market Segmentation: 1. By Application: 1.1 Cancer Research 1.2 Stem ...
- Tailored T-cell therapies neutralize viruses that threaten kids with PIDon November 18, 2019 at 9:38 am
Catherine Bollard, M.B.Ch.B., M.D., director of the Center for Cancer and Immunology Research at Children's National and the ... experience repeated and sometimes rare infections that can be life ...
- Global Cell Expansion Market Analysis 2019 | Industry Key Players, Share, Size, Trends, Sales, Supply, Demand, Analysis & Forecast to 2024on November 18, 2019 at 7:42 am
Disposables), By Cell Type (Human Cell and Animal Cell), By Application (Regenerative Medicine & Stem Cell Research and Cancer & Cell Based Research), By Region (North America, Europe, Asia Pacific, ...
- Leading Alternative Healing Director of Total Health Institute Reviews and Receives 3rd Fellowship in Stem Cell Therapyon November 15, 2019 at 6:32 pm
Most recently Dr. Nemec received his fellowship in Stem Cell Therapy to add to his other fellowships in Regenerative Medicine and Integrative Cancer Therapies. Dr. Nemec has overseen patient care for ...
- Aspirin enhances cisplatin sensitivity of resistant non-small cell lung carcinoma stem-like cells by targeting mTOR-Akt axis to repress migrationon November 15, 2019 at 2:18 am
Conventional chemotherapeutic regimens are unable to prevent metastasis of non-small cell lung carcinoma (NSCLC) thereby leaving cancer incurable. Cancer stem cells (CSCs) are considered to be the ...
- Cocker spaniel with cancer to receive stem cells from mother living 4,000 miles awayon November 14, 2019 at 12:05 pm
A 6-year-old cocker spaniel in California that was recently diagnosed with cancer is slated to receive stem cells from her mother living 4,000 miles away in the United Kingdom. Coco the cocker spaniel ...
- Extracellular Microenvironmental Change by B16F10 Melanoma-derived Proteins Induces Cancer Stem-like Cell Properties from NIH3T3 Cellson November 14, 2019 at 3:20 am
Cancer stem-like cells (CSCs) can generate solid tumors through the properties of stem cells such as self-renewal and differentiation and they cause drug resistance, metastasis and recurrence.
- New biomarker for cancer stem cellson November 13, 2019 at 6:38 pm
Gomika Udugamasooriya, an Associate Professor of the College of Pharmacy at the University of Houston, has found a new biomarker that exists in cancer stem cells. In Nature Scientific Reports, ...
- Discovery: New biomarker for cancer stem cellson November 13, 2019 at 12:23 pm
Because they are a mixed bag, no one drug exists to attack them. But now, a University of Houston College of Pharmacy associate professor has discovered a new biomarker in cancer stem cells that ...
- Cancer Survivor Running Disney World Half Marathon Receives Medal From Life-Saving Stem Cell Donoron November 12, 2019 at 4:11 pm
When Boyd Dunleavey was diagnosed with acute myeloid Leukemia in 2011, doctors gave him a 10% chance of surviving more than a few months without a stem cell transplant from a donor outside of his ...
via Google News and Bing News